Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Celgene (CELG) is one of two firms other than GSK that are considering buying Human Genome...

  • Sunday, July 8, 2012, 3:00 AM ET
    Celgene (CELG) is one of two firms other than GSK that are considering buying Human Genome (HGSI) and are holding talks with the company, Reuters reports. There's no word on who the second suitor is, although any deal would most likely be a merger of equals. With Human Genome holding an auction, the deadline for bids is July 16.
Track new comments on this story

This news story has 1 comment:

  •  
    $GSK owns $HGSI. $CELG is supposed to be stacked with their own drugs,no?
    8 Jul 2012, 07:55 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »